Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Class II device 510(k) exemptions granted

This article was originally published in The Gray Sheet

Executive Summary

Triiodothyronine uptake test systems (21 CFR 862.1715) and film dosimetry systems, a.k.a. film scanning systems (892.5050) are exempted from FDA premarket notification requirements effective Jan. 8. The exemption for the film dosimetry system is limited only to systems intended for quality control use, the agency says in a same-day Federal Register notice. FDA's actions come in response to previous requests submitted by Abbott Labs and Radiological Imaging Technology, respectively. The two petitions are the first to be approved by FDA under procedures mandated by the FDA Modernization Act. Five have been denied by the agency ("The Gray Sheet" Dec. 7, 1998, In Brief)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011154

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel